On injectables, my levels came back at anywhere from 1,000-4,000 pg/ml, this is perfectly normal and to be expected. How high or low the level comes back at depends on when you go in for testing, the day before the next injection, the day after, 3-4 days after, etc. On day 3, my levels were in excess of 2,000 pg/ml, on day 5, in the low 1,000's.
It is intriguing to me that while the recommendations for transsexual women include high doses of injectable estrogen, high levels which should be expected on such high doses create such a response where doses are reduced immediately. Especially considering that overall, as stated below, the evidence in favor of high estradiol levels causing major health complications is lacking while the opposite seems, in general, true as regards to bio-identical estradiol.
It also seems strange to me that in the first decades of treatment of transsexual women, very high doses of sometimes relatively harmful estrogens were prescribed to our population with no sign of being overly worried because the evidence was lacking and now with significantly safer forms of estrogens and some evidence suggesting they may indeed be relatively safe, even in higher doses, such prudence and caution is exercised.
I personally fared worst (i.e. breast growth) on injectables with very high levels of E2, the why of that remains a mystery. Lower levels with oral estradiol or gel produced better results as far as breast growth goes.
Yet, in studies where higher doses relative to mine were given to ciswomen by injections, authors noted impressive results in terms of secondary sexual development, including breast growth. Some transwomen also do quite well on injections and higher levels relative to other forms.
As far as health risks, my own test results in the course of three years on high dose E injections and those found in studies using high doses of bio-identical estrogen parenterally (injections, pellets, patches) in cismen, ciswomen and transwomen would suggest that they are minimal to none. Doctors are usually unaware of these studies.
Also, pregnant women have levels in excess of 1,000 pg/ml (as high as 75,000 pg/ml) for up to 9-10 months. Despite this, the female (and human) population is not dwindling and the risk of DVT in this population is a mere 0.1%.
Putting things in perspective, looking at other studies where high doses of oral bio-identical estradiol were taken by ciswomen, and also taking into account the minimal impact estradiol has on hepatic markers due to its molecular structure and quick metabolization (and other favorable effects it may have on coagulation, as was found in certain studies), the current generalized approach to high levels of estradiol in transwomen merits a re-assessment, I think.